Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Withdrawn2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnnot_applicable

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

NCT04486586
completednot_applicable

Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy

NCT03728582
withdrawnnot_applicable

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

NCT02622945

Clinical Trials (3)

Showing 3 of 3 trials
NCT04486586Not Applicable

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

Withdrawn
NCT03728582Not Applicable

Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy

Completed
NCT02622945Not Applicable

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3